Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Sun, Yuemei; Wu, Mengwan; Zhou, Mingxiu; Luo, Xing; Guo, Yan; Bai, Hansong; Zhang, Zican; Tian, Wei; Wang, Xiaoshan; Bai, Yifeng; Zhu, Xueqiang; Pan, Haixia; Deng, Ying; Hu, Honglin; Xia, Jianling; Hao, Xinbao; Han, Liangfu; Wei, Min; Liu, Yingyi; Zeng, Ming

doi:10.1186/s12885-020-07122-7

BMC Cancer

Article metrics
Last updated: Fri, 19 Apr 2024 4:21:43 Z

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Access & Citations

1703

Article Accesses
2

Web of Science
3

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com